Safety and Tolerability of GV150526 (a Glycine Site Antagonist at the N -Methyl- <scp>d</scp> -Aspartate Receptor) in Patients With Acute Stroke
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Functional evaluation : Barthel index
1965 • 12,604 citations
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study
1997 • 523 citations
Clinical Experience With Excitatory Amino Acid Antagonist Drugs
1995 • 499 citations
Reliability of the National Institutes of Health Stroke Scale
2022 • 380 citations
Mitral valve replacement
2004 • 332 citations
The Glycine Antagonist GV150526 Protects Somatosensory Evoked Potentials and Reduces the Infarct Area in the MCAo Model of Focal Ischemia in the Rat
1997 • 88 citations
Neurotoxicity of NMDA receptor antagonists: an overview.
1994 • 83 citations
Identification and pharmacological characterization of GV150526, a novel glycine antagonist as potent neuroprotective agent
1998 • 26 citations
Quantitative Analysis of Long-Term Survival and Neuritogenesisin Vitro:Cochleovestibular Ganglion of the Chick Embryo in BDNF, NT-3, NT-4/5, and Insulin
1997 • 23 citations
Sacral pseudoradiculopathy due to centrum semiovale stroke
1996 • 3 citations